Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monoclonal antibody
Pharma
Pasatru approved by FDA as 2nd drug for rare bone lesion disease
The FDA approved Regeneron's Pasatru for patients with FOP, an ultra-rare genetic condition that causes soft tissues to turn to bone.
Donavyn Coffey
Aug 19, 2026 2:35pm
Merck seeks Enflonsia expansion to rival Sanofi, AZ's Beyfortus
Feb 19, 2026 10:40am
InflaRx may find path forward for COVID drug in skin disorder
Jan 2, 2026 10:25am
GSK scoops up yet another FDA approval, this time in asthma
Dec 17, 2025 8:30am
FDA signs off on Enflonsia, Merck's RSV shot for infants
Jun 9, 2025 4:33pm
InflaRx scraps vilobelimab study in rare skin disorder
May 28, 2025 9:55am
